atrial fibrillation
Conditions
Interventions
None listed
Sponsors
Johnson and Johnson K.K.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Subjects must meet all of the following inclusion criteria to be eligible for participation in this registry: 1.Patients who provide signed informed consent to participate in the registry 2.Patients with drug refractory symptomatic paroxysmal AF or patients with persistent AF for less than 6 months who, in the opinion of the investigator, are candidates for catheter ablation per standard-of-care 3.Patients who plan to have pulmonary vein isolation (PVI), of which AI is usable 4.Patients must be 20 years of age or older 5.Patients undergoing AF ablation for the first time
Exclusion criteria
Exclusion criteria: Subjects who meet any of the following exclusion criteria are not eligible for enrollment: 1.Patients with persistent AF with a continuous episode lasting longer than 6 months or patients with long-standing persistent AF 2.Patients who previously underwent AF ablation 3.Women of childbearing potential who are, or plan to become, pregnant during the time of the study 4.Patients who have a life expectancy of less than 12 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess acute and long-term clinical outcomes, including procedural efficiency, safety, and long-term effectiveness of catheter ablation with RF catheters guided by AI in patients with paroxysmal and early persistent AF in a Japanese population. | — |
Countries
Japan
Contacts
Public ContactBunmoku Tei
IQVIA Services Japan K.K. Real World Evidence Services
Outcome results
None listed